表紙
市場調査レポート

治療用ボツリヌス毒素 (BTX) の世界市場

Therapeutic Botulinum Toxin | Market Analysis | Global | 2016

発行 Decision Resources Group - Medtech Solutions 商品コード 76548
出版日 ページ情報 英文 66 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。
Back to Top
治療用ボツリヌス毒素 (BTX) の世界市場 Therapeutic Botulinum Toxin | Market Analysis | Global | 2016
出版日: 2016年03月23日 ページ情報: 英文 66 Pages
概要

世界の治療用ボツリヌス毒素市場は、新たに承認された適応症、ボツリヌス毒素の反復療法、および好ましい医療費償還環境に後押しされ、処置数・売上数が大幅に拡大することにより、2024年まで力強い成長を見せるでしょう。

当レポートでは、世界および米国、欧州、、日本における治療用ボツリヌス毒素市場の現況と今後の予測、競合情勢、市場シェアの分析などを提供しています。

第1章 世界の治療用ボツリヌス毒素市場

  • 市場概要
  • 市場定義
  • 市場予測データ
  • 全般的な市場動向
  • 競合概要
  • 競合情勢
  • 市場シェア
  • 市場因子と発展

第2章 米国の治療用ボツリヌス毒素市場

  • 市場概要
  • 市場定義
  • 市場予測データ
  • 競合概要
  • 市場シェア

第3章 欧州の治療用ボツリヌス毒素市場

  • 市場概要
  • 市場定義
  • 市場予測データ
  • 競合概要
  • 市場シェア

第4章 日本の治療用ボツリヌス毒素市場

  • 市場概要
  • 市場定義
  • 市場予測データ
  • 競合概要
  • 市場シェア

付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: M360BT0003

The global therapeutic BTX market will grow strongly through 2024, with newly approved indications, the need for repeat BTX treatments, and a largely favorable reimbursement environment driving significant procedure volume and unit sales expansion.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for therapeutic BTX in the US, France, Germany, Italy, Spain, the UK, and Japan across a 10-year period

Questions Answered in This Report:

New indication approvals will be significant drivers in the therapeutic BTX market.

  • Which indications contribute the most to growth?
  • What regional differences exist regarding indication approvals?
  • What new indications have the largest market potential?

The global therapeutic markets are becoming more and more consolidated.

  • What are some key competitive strategies being employed to succeed in the market?
  • How do the competitive landscapes differ by region, and what considerations must companies make in particular markets?

Markets vary greatly by region in terms of size and growth, with the Japanese market experiencing the fastest growth globally.

  • What key drivers contribute to a market's relative size and growth?
  • What factors most significantly affect pricing within markets?

Emerging products could have significant impact on the BTX market.

  • Will emerging products expand on or compete against the existing BTX market?
  • What are some potential competitive advantages emerging products might have?

Table of Contents

Table of Contents

Tables and Figures

Executive Summary

Version History

1 Global Therapeutic Botulinum Toxin Market

  • 1.1 Market Highlights
  • 1.2 Market Definitions
  • 1.3 Market Forecast Data
    • 1.3.1 By Indication (Procedures Only)
  • 1.4 General Market Trends
    • 1.4.1 By Indication (Procedures Only)
  • 1.5 Competitive Highlights
  • 1.6 Competitive Landscape
  • 1.7 Market Shares
  • 1.8 Market Factors and Developments

2 US Therapeutic Botulinum Toxin Market

  • 2.1 Market Highlights
  • 2.2 Market Definitions
  • 2.3 Market Forecast Data
  • 2.4 Competitive Highlights
  • 2.5 Market Shares

3 European Therapeutic Botulinum Toxin Market

  • 3.1 Market Highlights
  • 3.2 Market Definitions
  • 3.3 Market Forecast Data
  • 3.4 Competitive Highlights
  • 3.5 Market Shares

4 Japanese Therapeutic Botulinum Toxin Market

  • 4.1 Market Highlights
  • 4.2 Market Definitions
  • 4.3 Market Forecast Data
  • 4.4 Competitive Highlights
  • 4.5 Market Shares

Appendix: Methodology

Appendix: Acronyms and Initialisms

Appendix: Bibliography

Tables and Figures

  • Figure 1: Therapeutic BTX Market, by Region, Global (USD), 2014-2024
  • Table 1: Therapeutic BTX Market Landscape, Global (USD), 2015 and 2024
  • Table 2: Therapeutic BTX Revenue Market Share Rankings, by Region, Global, 2015
  • Table 3: Companies Mentioned
  • Table 4: Factors Impacting the Therapeutic BTX Market, Global
  • Table 5: Recent Events in the Therapeutic BTX Market, Global
  • Table 6: Emerging Products for the Therapeutic BTX Market, Global
  • Table 7: Geographies Covered, Global
  • Table 8: Average Currency Exchange Rates
  • Table 9: Therapeutic BTX Procedures Covered
  • Table 10: Approved Indications, by Brand, US, 2015
  • Table 11: Approved Indications, by Brand, Europe, 2015
  • Table 12: Approved Indications, by Brand, Japan, 2015
  • Table 13: Therapeutic BTX Product Overview, Global, 2015
  • Table 14: Version History
  • Figure 2: Therapeutic BTX Market, by Region, Global (USD), 2014-2024
  • Table 15: Therapeutic BTX Product Overview, Global, 2015
  • Table 16: Mean Dosages, by Indication and Brand, Global, 2015
  • Table 17: Approved Indications, by Brand, US, 2015
  • Table 18: Approved Indications, by Brand, Europe, 2015
  • Table 19: Approved Indications, by Brand, Japan, 2015
  • Table 20: Therapeutic BTX Procedures, by Region, Global, 2014-2024
  • Table 21: Therapeutic BTX Market, by Region, Global (USD), 2014-2024
  • Table 22: Therapeutic BTX Market Growth, by Region, Global, 2015-2024
  • Table 23: Therapeutic BTX Procedures, by Indication, Global, 2014-2024.
  • Figure 3: Therapeutic BTX Revenue Market Shares, Global, 2015
  • Table 24: Therapeutic BTX Revenue Market Shares, by Region, Global, 2015
  • Table 25: Factors Impacting the Therapeutic BTX Market, Global
  • Table 26: Recent Events in the Therapeutic BTX Market, Global
  • Table 27: Emerging Products for the Therapeutic BTX Market, Global
  • Figure 4: Therapeutic BTX Market, US (USD), 2014-2024
  • Table 28: Therapeutic BTX Procedures, by Indication, US, 2014-2024
  • Table 29: Therapeutic BTX Market, US (USD), 2014-2024
  • Figure 5: Therapeutic BTX Revenue Market Shares, US, 2015
  • Table 30: Therapeutic BTX Revenue Market Shares, US, 2015
  • Figure 6: Therapeutic BTX Market, by Country, Europe (USD), 2014-2024
  • Table 31: Therapeutic BTX Procedures, by Indication, Europe, 2014-2024
  • Table 32: Therapeutic BTX Procedures, by Country, Europe, 2014-2024
  • Table 33: Therapeutic BTX Procedures, by Indication, France, 2014-2024
  • Table 34: Therapeutic BTX Procedures, by Indication, Germany, 2014-2024
  • Table 35: Therapeutic BTX Procedures, by Indication, Italy, 2014-2024
  • Table 36: Therapeutic BTX Procedures, by Indication, Spain, 2014-2024
  • Table 37: Therapeutic BTX Procedures, by Indication, UK, 2014-2024
  • Table 38: Therapeutic BTX Market, by Country, Europe (USD), 2014-2024
  • Table 39: Therapeutic BTX Market, by Country, Europe (EUR and GBP), 2014-2024
  • Table 40: Therapeutic BTX Market Growth, by Country, Europe, 2015-2024
  • Figure 7: Therapeutic BTX Revenue Market Shares, Europe, 2015
  • Table 41: Therapeutic BTX Revenue Market Shares, by Country, Europe, 2015
  • Figure 8: Therapeutic BTX Market, Japan (USD), 2014-2024
  • Table 42: Therapeutic BTX Procedures, by Indication, Japan, 2014-2024
  • Table 43: Therapeutic BTX Market, Japan (USD), 2014-2024
  • Figure 9: Therapeutic BTX Revenue Market Shares, Japan, 2015
  • Table 44: Therapeutic BTX Revenue Market Shares, Japan, 2015
  • Table 45: Acronyms and Initialisms
Back to Top